The Company will host a conference call to discuss those results and highlights on
To join the conference call without operator assistance, you may register and enter your phone number at https://emportal.ink/3RSJ3aC to receive an instant automated call back.
You can also dial direct to be entered to the call by an Operator. (Traditional conference call instructions here)
Conference ID: 50959607
Date:
Time:
Dial-in numbers: 1-888-664-6392 or 416-764-8659
Audio replay numbers: 1-888-390-0541 or 416-764-8677
Replay code: 959607 #
A live audio webcast of the conference call will be available via: https://app.webinar.net/5z6nmw5MNAw
About
Forward Looking Statements
This press release contains forward-looking statements about Valeo's objectives, strategies and businesses that involve risks and uncertainties. These statements are 'forward-looking' because they are based on our current expectations about the markets we operate in and on various estimates and assumptions. Actual events or results may differ materially from those anticipated in these forward-looking statements if known or unknown risks affect our business, or if our estimates or assumptions turn out to be inaccurate.
Contact:
Tel: 514-693-8830
Email: steve.saviuk@valeopharma.com
Tel: 438-870-3079
Email: pascal.tougas@valeopharma.com
(C) 2024 Electronic News Publishing, source